ANI Pharmaceuticals launches Etodolac 300mg oral capsules ANI Pharmaceuticals.

Arthur S. Przybyl, Chief and President Executive Officer stated, ‘We are very happy to announce the launch of our second product from the portfolio of authorized generic products we obtained from Teva in January 2014.’.. ANI Pharmaceuticals launches Etodolac 300mg oral capsules ANI Pharmaceuticals, Inc. today announced the start of Etodolac 300mg oral capsules, indicated for make use of in the management of the symptoms and signals of osteoarthritis, rheumatoid arthritis, and acute pain. The US market for Etodolac 300mg capsules totals $9 million on a trailing 12 month basis, per IMS Health. Ahead of today's announcement, only two companies marketed the product.Hill & Thomas A-Lifestyle Medical, Inc., the pioneer and leading supplier of computer-assisted coding products and services to the healthcare sector, announced today the forging of an exclusive agreement with the biggest and oldest independently possessed radiology group in Ohio, Cleveland-centered Drs. Hill & Thomas Co. Under the agreement, A-Life Medical will provide exclusive CAC services that straight address radiology procedures. The mix of Actus and LifeCode can increase coder productivity by up to 300 % through improved coding workflow efficiencies, code traceability and consistency for compliance. Related StoriesHealthcare technology social event of the entire year opens entriesReducing hospital readmissions through Transitional Care: an interview with Rani KhetarpalAddressing standard of living needs in prostate cancer: an interview with Professor Louis DenisAfter exploring other coding alternatives recently, Drs.